Lipella Pharmaceuticals Statistics
Total Valuation
LIPO has a market cap or net worth of $7.52 million. The enterprise value is $3.05 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LIPO has 2.55 million shares outstanding. The number of shares has increased by 67.07% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +67.07% |
| Shares Change (QoQ) | +69.99% |
| Owned by Insiders (%) | 11.44% |
| Owned by Institutions (%) | 4.18% |
| Float | 2.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.30 |
| Forward PS | n/a |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.21 |
| Quick Ratio | 5.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -154.54% and return on invested capital (ROIC) is -95.70%.
| Return on Equity (ROE) | -154.54% |
| Return on Assets (ROA) | -81.17% |
| Return on Invested Capital (ROIC) | -95.70% |
| Return on Capital Employed (ROCE) | -127.25% |
| Revenue Per Employee | $74,267 |
| Profits Per Employee | -$732,997 |
| Employee Count | 7 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.78% in the last 52 weeks. The beta is 0.27, so LIPO's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -43.78% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 60.75 |
| Average Volume (20 Days) | 29,750 |
Short Selling Information
The latest short interest is 133,447, so 5.24% of the outstanding shares have been sold short.
| Short Interest | 133,447 |
| Short Previous Month | 17,271 |
| Short % of Shares Out | 5.24% |
| Short % of Float | 5.91% |
| Short Ratio (days to cover) | 0.82 |
Income Statement
In the last 12 months, LIPO had revenue of $519,867 and -$5.13 million in losses. Loss per share was -$3.85.
| Revenue | 519,867 |
| Gross Profit | -3.24M |
| Operating Income | -5.19M |
| Pretax Income | -4.74M |
| Net Income | -5.13M |
| EBITDA | -5.19M |
| EBIT | -5.19M |
| Loss Per Share | -$3.85 |
Full Income StatementBalance Sheet
The company has $4.23 million in cash and $23,997 in debt, giving a net cash position of $4.20 million or $1.65 per share.
| Cash & Cash Equivalents | 4.23M |
| Total Debt | 23,997 |
| Net Cash | 4.20M |
| Net Cash Per Share | $1.65 |
| Equity (Book Value) | 4.08M |
| Book Value Per Share | 1.60 |
| Working Capital | 4.05M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.99M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.99M |
| FCF Per Share | -$1.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -998.47% |
| Pretax Margin | -986.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |